Precursors
JK7-TMA
JK7-TMA
[18F]JK-PSMA-7
Prostate cancer
JK7-TMA
JK7-TMA is a urea‑based PSMA ligand designed for the efficient production of [18F]JK‑PSMA‑7 via direct late‑stage radiofluorination of a trimethylammonium triflate precursor.
This tracer targets prostate-specific membrane antigen (PSMA) overexpressed in prostate cancer cells, enabling superior visualization of primary tumors, lymph node metastases, and bone lesions, even small PSMA-positive lesions missed by other agents.
Synthesis set avalaible for:
Technical information
Storage conditions & Shelf life
Get a custom offer for this precursor
Ensure consistent radiochemical yield with our strictly controlled, industry-essential compounds. Select your required grade (GMP/Research) and quantity to receive a personalized proposal from our team.
Related contents
Related Products
